Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

NSAID Use in GERD Patients: Guidelines for Safe Prescription

Introduction to NSAID-Associated Risks

  • The American Gastroenterological Association recommends that patients with GERD should limit NSAID use to the shortest possible duration, ideally less than 7 days, to minimize the risk of gastrointestinal complications 1

Mandatory Gastroprotection Strategy

  • The American College of Gastroenterology suggests that proton pump inhibitors are the most effective agents for healing NSAID-associated ulcers and preventing complications, and should be continued at standard once-daily dosing throughout NSAID therapy 2, 3, 4
  • The American College of Gastroenterology advises against relying on H2-receptor antagonists for gastroprotection, as they are inadequate, and recommends using PPIs instead 1

Risk Stratification Algorithm

  • The American Heart Association and the American College of Gastroenterology recommend assessing high-risk features, including prior history of peptic ulcer disease or GI bleeding, concomitant anticoagulant or corticosteroid use, age >65 years, severe or erosive esophagitis, and Barrett's esophagus, before prescribing NSAIDs to GERD patients 2, 5

Safe NSAID Prescription

  • The American College of Gastroenterology recommends using ibuprofen at low doses (≤1200 mg/day) and limiting the duration to less than 7 days if possible, with mandatory PPI co-therapy, in high-risk patients 1, 4